Edge
StocktwitsEarnings

Official STOCKTWITS Representative

$MYGN Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.46 up 87.11% YoY
• Reported revenue of $190.7M down -10.51% YoY
• Myriad Genetics provides full-year 2026 financial guidance of $770 million to $790 million in revenue and expects an adjusted gross margin percentage in the range of 66% to 67%.Price since post
Advertisement|Remove ads.